炎症性肠病住院患者静脉血栓栓塞发生率上升:一项全国性分析
该研究利用美国全国住院患者样本2000至2018年数据,评估炎症性肠病(IBD)住院患者静脉血栓栓塞(VTE)的趋势、危险因素及死亡率。期间IBD住院共4,859,728例,VTE 128,236例(2.6%),相关死亡6352例;VTE发生率从每万例住院192例升至295例(AAPC 2.4%,95%CI 1.4%, 3.4%,p<0.001)。多变量分析显示年龄增长、男性、溃疡性结肠炎(aOR 1.30,95%CI 1.26, 1.33)、非西班牙裔黑人及慢性皮质类固醇使用(aOR 1.22,95%CI 1.16, 1.29)与VTE相关住院风险增加有关。
要点
- IBD住院患者VTE发生率从每万例192例升至295例,AAPC 2.4%(95%CI 1.4%, 3.4%,p<0.001)。
- 溃疡性结肠炎患者VTE相关住院风险增加(aOR 1.30,95%CI 1.26, 1.33)。
- 慢性皮质类固醇使用与VTE相关住院风险增加有关(aOR 1.22,95%CI 1.16, 1.29)。
核心结论
- IBD患者VTE相关住院率呈上升趋势,需持续开展教育与风险降低工作。
研究设计与样本
- 基于美国全国住院患者样本2000至2018年的全国性分析,采用美国国家癌症研究所Joinpoint回归程序评估VTE时间趋势,估计值以平均年度百分比变化(AAPC)及95%CI表示。
- IBD住院共4,859,728例,其中VTE 128,236例(2.6%),相关死亡6352例。
主要发现
- IBD住院患者VTE发生率从每万例住院192例升至295例(AAPC 2.4%,95%CI 1.4%, 3.4%,p<0.001)。
- 按溃疡性结肠炎与克罗恩病分层、以及按深静脉血栓与肺栓塞分层后,趋势仍显著。
- 多变量分析中,年龄增长、男性、溃疡性结肠炎(aOR 1.30,95%CI 1.26, 1.33)、非西班牙裔黑人及慢性皮质类固醇使用(aOR 1.22,95%CI 1.16, 1.29)与VTE相关住院风险增加有关。
关键数值与推荐
- VTE发生率从每万例住院192例升至295例(AAPC 2.4%,95%CI 1.4%, 3.4%,p<0.001)。
- 溃疡性结肠炎与VTE相关住院风险增加有关(aOR 1.30,95%CI 1.26, 1.33)。
- 慢性皮质类固醇使用与VTE相关住院风险增加有关(aOR 1.22,95%CI 1.16, 1.29)。
临床怎么用
- 原文结论提出需持续开展教育与风险降低工作;原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. AIMS: To assess national trends in VTE-associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events METHODS: Using the U.S. Nationwide Inpatient Sample from 2000-2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs). RESULTS: Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p < 0.001), and remained significant when stratified by ulcerative colitis (UC) and Crohn's disease as well as by deep vein thrombosis and pulmonary embolism. On multivariable analysis, increasing age, male sex, UC (aOR: 1.30, 95%CI 1.26, 1.33), identifying as non-Hispanic Black, and chronic corticosteroid use (aOR: 1.22, 95%CI 1.16, 1.29) were associated with an increased risk of a VTE-associated hospitalisation. CONCLUSION: Rates of VTE-associated hospitalisations are increasing among patients with IBD. Continued efforts need to be placed on education and risk reduction.
引用
- Faye AS, Lee KE, Dodson J, et al. Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Aliment Pharmacol Ther. 2022. PMID: 35879231. doi:10.1111/apt.17162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。